NCT05170724 Global Managed Access Program Cohort for Remibrutinib in Adult Patients With Chronic Spontaneous Urticaria Status AVAILABLE Phase N/A
NCT05168748 CD19- and CD22-directed CAR-T Cell Therapy in Patients With Acute Lymphoblastic Leukemia Status WITHDRAWN Phase PHASE1
NCT05162638 Immune Profiles in Multiple Sclerosis (MS) Patients and Healthy Volunteers Through Thoracic Duct Cannulation Status ENROLLING_BY_INVITATION Phase NA
NCT05161195 Roll-over Study to Allow Continued Access to Ribociclib Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT05157087 XOLAIR (Omalizumab) Outcomes in Pediatric Allergic Asthma Patients in the United States Status COMPLETED Phase N/A
NCT05156281 Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-2) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05155709 A Study of Siremadlin in Combination With Venetoclax Plus Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Chemotherapy. Status COMPLETED Phase PHASE1
NCT05155098 2 Years Prospective Study to Collect Real-life Data on the Retention, Quality of Life, Effectiveness and Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe Plaque Psoriasis, Psoriatic Arthritis, Ankylosing Spondylitis and Non-radiographic Axial Spondyloarthritis Status COMPLETED Phase N/A
NCT05153135 Description of Treatment Patterns and Description and Comparison of Healthcare Resource Utilization and Costs of Women With Metastatic HR+/HER2- Breast Cancer Treated With CDK4/6 Inhibitors Status COMPLETED Phase N/A
NCT05147220 Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-1) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05146830 A Long-Term Follow-Up Study of Participants With Cystinosis Who Previously Received CTNS-RD-04 Status ENROLLING_BY_INVITATION Phase N/A
NCT05146687 Real-world Evaluation of Prevalence of Ocular Adverse Events in Patients With Neovascular (Wet) Age-related Macular Degeneration (AMD) Who Received Anti-vascular Endothelial Growth Factor (VEGF) Agents (Komodo Health) Status COMPLETED Phase N/A
NCT05143229 Alpelisib And Sacituzumab Govitecan For Treatment Of Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05142696 A Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed ES-SCLC Patients in Combination With Carboplatin, Etoposide and Atezolizumab Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05141240 A Real-world Analysis of Concomitant Medication Use Among Metastatic Breast Cancer Patients Treated With CDK4/6 Inhibitors Status COMPLETED Phase N/A
NCT05135000 Study of Efficacy and Safety of LTP001 in Pulmonary Arterial Hypertension Status TERMINATED Phase PHASE2
NCT05132075 Study of JDQ443 in Comparison With Docetaxel in Participants With Locally Advanced or Metastatic KRAS G12C Mutant Non-small Cell Lung Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05126277 Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05124925 Biopsy Based Study to Understand Mechanism of Action of Ianalumab in Salivary Glands and Explore Relationships With Clinical Assessments. Status COMPLETED Phase PHASE2